Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)
by on Monday, May 14th, 2012 | No Comments
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Crizotinib (Xalkori)
Sponsors: Pfizer; Pfizer
Active, not recruiting – verified May 2012
Read the original post: Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)